GLOBAL CANCER INSTITUTE INC (EIN 461708378) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2013

Legal Domicile

Principal Officer

PAUL DAMP

Phone

9175202475

Tax Period

2023-01-01 to 2023-12-31

GLOBAL CANCER INSTITUTE INC, founded in 2013, is a micro nonprofit in the Diseases & Disorders sector that reported $76K in total revenue in fiscal year 2023. Revenue decreased 6% compared to the prior year. Expenses of $229K exceeded revenue, resulting in a 201% operating deficit.

Mission

TO IMPROVE THE SURVIVAL AND QUALITY OF LIFE OF UNDERSERVED CANCER PATIENTS WORLDWIDE BY RESEARCHING BARRIERS TO CANCER CONTROL, ENHANCING ACCESS TO CANCER CARE AND IMPROVING CLINICAL CARE AND EXPERTISE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $75,039

Program Service Revenue $0

Investment Income $907

Other Revenue $0

TOTAL REVENUE $75,946

Expense Breakdown

Grants Paid $0

Salaries & Benefits $211,988

Fundraising Expenses $0

Program Expenses $194,796

Other Expenses $16,619

TOTAL EXPENSES $228,607

Year-over-Year Comparison

	2023	2022	Change
Revenue	$75,946	$80,381	-0.1%
Expenses	$228,607	$253,991	-0.1%
Net Income	$-152,661	$-173,610	-0.1%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ANDREA JUNG	DIRECTOR/CHAIRMAN OF THE B	1.00	Director	$0	$0	$0
PAUL DAMP	PRESIDENT/DIRECTOR	1.00	Officer Director	$0	$0	$0
MARK HURLBERT	DIRECTOR	1.00	Director	$0	$0	$0
KEVIN HONEYCUTT	SECRETARY/TREASURER/DIRECT	1.00	Director	$0	$0	$0
CAROLYN RICCI	EXECUTIVE DIRECTOR	40.00	Highest	$151,891	$0	$151,891

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2023	$75,946	$228,607	$12,607	$-152,661
2022	$80,381	$253,991	$165,268	$-173,610
2021	$311	$104,434	$338,878	$-104,123
2020	$15,042	$82,670	$443,001	$-67,628
2019	$106,115	$47,239	$510,629	$58,876
2018	$60,886	$75,344	$451,753	$-14,458

GLOBAL CANCER INSTITUTE INC